IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions. The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue. As of August 31, 2025, the company had a total of 18 permanent employees in various departments.
Revenue Growth
Sotefin Bharat
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
Sotefin Bharat SME | 16th Jul 2026 - 20th Jul 2026 | 89.76 Cr | 600 Shares | ₹ 178.00 | |
Caliber Mining & Logistics Mainboard | 17th Jul 2026 - 21st Jul 2026 | 450.00 Cr | 35 Shares | ₹ 402.00 |

Open Date
Mar 20, 2026
Close Date
Mar 24, 2026
Min Investment
₹2,48,000
Lot Size
1000 Shares
Issue Size
₹29.14 Cr
Price Range
₹117 - ₹117
Listing Date
Mar 30, 2026
IPO Doc
RHP PDFCompany Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat. ₹2.99 crore will fund global product registration and development. The company will use ₹1.65 crore to fund its marketing and promotional activities. The company will utilise ₹8 crore for funding the working capital of the business. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Set up of R&D center
43.72%
Product registration and development
10.31%
Marketing expenses
5.72%
Working capital
27.59%
General corporate purposes
12.63%
The company will utilise ₹12.68 crore for setting up an R&D center at Valsad, Gujarat.
₹2.99 crore will fund global product registration and development.
The company will use ₹1.65 crore to fund its marketing and promotional activities.
The company will utilise ₹8 crore for funding the working capital of the business.
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).
In Cr.
| Key Performance Indicator | 31-Oct-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) |
|---|---|---|---|
| Revenue | 36.93 | 58.54 | 27.66 |
| EBITDA | 6.51 | 9.09 | 5.26 |
| Expenses | |||
| Profit After Tax | 6.06 | 8.61 | 2.93 |
| Assets | 45.57 | 39.98 | 22.68 |
| Net Worth | 36.47 | 30.42 | 15.06 |
| Reserves | 30.04 | 23.98 | 9.95 |
| Borrowing | 4.81 | 5.05 | 2.86 |
Parth B Goyani
Goyani Sumit Babubhai
59.28%
43.44%
Speciality Medicines
913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.